Institutional investors hold a majority ownership of ACT through the 86.01% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended September 2013, these large investors purchased a net $7.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.2 Million shares of Actavis PLC
VIKING GLOBAL INVESTORS LP Bought 1.8 Million shares of Actavis PLC
WELLS CAPITAL MANAGEMENT, INC. Bought 1.1 Million shares of Actavis PLC